Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
Indo Borax & Chemicals Limited is an Indian specialty chemicals manufacturer focused on boron-based compounds and derivatives used in glass, ceramics, detergents, and agricultural applications. The company operates refining and processing facilities in India, serving domestic and export markets with products like borax pentahydrate, boric acid, and boron derivatives. With zero debt, exceptional liquidity (11.91x current ratio), and 53% gross margins, the company demonstrates strong pricing power in niche boron chemistry markets.
Indo Borax imports raw boron minerals (primarily from Turkey and South America) and refines them into high-purity boron compounds at Indian facilities. The company captures value through technical processing expertise, quality consistency, and serving fragmented Indian industrial customers who require reliable supply. Pricing power stems from technical specifications required by glass manufacturers and limited domestic competition in refined boron products. The 53% gross margin suggests strong value-add in purification and formulation processes. Zero debt structure provides flexibility to maintain inventory during raw material price volatility.
Indian glass and ceramics industry capacity utilization and expansion cycles
Boron mineral import costs and USD/INR exchange rate fluctuations
Domestic industrial production growth, particularly construction-related demand
Export competitiveness versus Chinese boron chemical producers
Raw material supply agreements and inventory management efficiency
Import dependency for raw boron minerals creates supply chain vulnerability and currency exposure - Turkey supplies ~70% of global boron, creating geopolitical concentration risk
Chinese overcapacity in boron chemicals could pressure export pricing and force domestic market share battles
Substitution risk in certain applications as glass manufacturers explore boron-free formulations for environmental reasons
Limited moat beyond processing expertise - competitors with backward integration into mining (like Rio Tinto's US Borax) have structural cost advantages
Fragmented customer base in India limits negotiating leverage versus large multinational chemical buyers
Technology risk if continuous processing innovations emerge that reduce purification costs
Negative operating cash flow of $0.7B against $1.8B revenue (39% of sales) indicates severe working capital strain or timing issues requiring investigation
Despite zero debt, cash burn at current rate could pressure the strong current ratio within 12-18 months if not reversed
High inventory risk given boron mineral price volatility - potential for write-downs if demand weakens further
high - Boron compounds are primarily consumed by cyclical industries including glass manufacturing (construction, automotive), ceramics (housing, infrastructure), and industrial applications. Indian GDP growth and industrial production directly drive demand. The -8.4% revenue decline amid 9.1% net income growth suggests recent volume weakness offset by margin expansion, typical of cyclical downturns where fixed cost leverage works in reverse.
Low direct sensitivity given zero debt, but moderate indirect exposure through customer industries. Rising rates in India dampen construction and housing activity, reducing glass and ceramics demand. However, the company's fortress balance sheet (11.91x current ratio) provides countercyclical advantage to maintain market share during credit-constrained periods. Valuation multiples may compress with rising rates given 3.9x P/S premium.
Minimal direct exposure with zero debt. However, customer credit quality matters - construction and manufacturing customers may face payment delays during credit tightening. The negative $0.7B operating cash flow (against $1.8B revenue) suggests working capital challenges, possibly from extended receivables or inventory buildup, which could indicate customer payment stress or demand softness.
value - The 56.9% one-year return suggests momentum exhaustion with recent 5-6% declines. Current 3.9x P/S and 11.3x EV/EBITDA appear elevated for a cyclical chemical company with negative cash flow, but zero debt and 13.7% ROE attract value investors seeking balance sheet quality. The stock likely appeals to India-focused funds seeking specialty chemical exposure with defensive characteristics (pricing power, niche products) but cyclical upside.
high - As a mid-cap specialty chemical company in an emerging market with concentrated product exposure and cyclical end markets, expect elevated volatility. The 56.9% annual return followed by recent declines demonstrates momentum swings. Currency exposure, raw material volatility, and small float likely amplify price movements around earnings and macro data.